These include the provision of affordable insulin,4 access to health care (including glucose monitoring and promptly available services for acute decompensation), and health education (including rapid recognition and detection of type 1 diabetes and ketoacidosis).5 This evidence concerns the gene INS and type 1 diabetes mellitus.